Phase 1 Study of Voyager’s Gene Therapy Shows Potential for Parkinson’s Patients – Parkinson’s News Today
|
Phase 1 Study of Voyager's Gene Therapy Shows Potential for Parkinson's Patients
Parkinson’s News Today To overcome the defect of AADC levels in neurons, Voyager Therapeutics developed a targeted gene therapy to directly deliver and promote the expression of the enzyme in a brain region called the putamen. Because patients with advance Parkinson's … |
